Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma

This study is testing a new treatment called SN301A — an injected drug that targets a protein called GPC3 — in patients with liver cancer (hepatocellular carcinoma) whose tumors express that protein. **You may be eligible if...** - You are between 18 and 70 years old - You have been diagnosed with liver cancer (hepatocellular carcinoma) - A lab test shows your tumor has high GPC3 protein expression - You have tried standard treatments or are not eligible for them - Your liver and organ function are adequate **You may NOT be eligible if...** - Your tumor does not express GPC3 - You are younger than 18 or older than 70 - Your liver or other organ function is too impaired - You have another active cancer or serious infection Talk to your doctor to see if this trial is right for you.